Blood Cancer Talks cover image

Episode 15. Management of Newly Diagnosed DLBCL (Including Bonus ASH22 Updates)

Blood Cancer Talks

00:00

The Toxicity of Polaric Stata in DLVCL

Polaric polar chip is not more toxic than archer that way from personal experience. That made me really excited, especially because I'm very interested in care for older adults. And actually men who were over the age of 60 did better on polar chip and they didn't have higher toxicity. How do you think about progression free survival or PFS as an end point specifically in DLVCL? Yeah, so I think it is important because in any of these trials, the cause of death is mostly lymphoma.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app